Some researchers proved that down-regulated expression levels of α-smooth muscle actin (SMA) and transforming growth factor (TGF)-β1 and improved liver fibrosis have been observed in silencing Gal-1 mouse models (30). The gene discussed is TGFB1; the disease is Hepatic fibrosis.